Octreotide and Insulin Human Interaction

Drug interaction information between Octreotide and Insulin Human.

Octreotide and Insulin Human have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Octreotide and Insulin Human. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Octreotide

Somatostatin Analog

Drug B

Insulin Human

Intermediate-Acting Insulin Combination

How They Interact

Octreotide can lower blood sugar levels, which adds to the effect of insulin and makes low blood sugar more likely.

FDA Label Information

7 DRUG INTERACTIONS Table 1: Clinically Significant Drug Interactions with HUMULIN 70/30 Drugs that May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics Intervention: Dose adjustment and increased frequency of glucose monitoring may be required when HUMULIN 70/30 is co-administered with these drugs.

Frequently Asked Questions

What SPL severity band is on file for Octreotide + Insulin Human/Insulin Isophane?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Octreotide has 14 labeled pairs on file vs Insulin Human's 11. In the moderate band specifically: Octreotide has 9 (also Insulin Aspart, Insulin Degludec, Insulin Detemir, Insulin Glargine); Insulin Human has 3 (also Fluoxetine, Pramlintide).

What mechanism field is on file for Octreotide and Insulin Human/Insulin Isophane?

Octreotide can lower blood sugar levels, which adds to the effect of insulin and makes low blood sugar more likely.

Octreotide's labeled portfolio outnumbers Insulin Human

SPL source-record counts only. This page's band is moderate · classes on file: Octreotide (Somatostatin Analog); Insulin Human (Intermediate-Acting Insulin Combination).

Octreotide

0 major · 9 moderate · 5 minor · 14 total

Insulin Human

0 major · 3 moderate · 8 minor · 11 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.